Etta Biotech was established in Nov. 2014 in Suzhou Industrial Park, it is an electroporator specialist dedicated for developing of advanced electroporation technology and manufacturer of electroporator products. It was funded by experts in multiple subjects and fields, including 6 doctors and 4 top-university professors. Etta Biotech is a National Hi-Tech Enterprise and a Gusu's Leading-Talent Enterprise.
Etta Biotech,with its self-developed and owned electroporation patented technologies, is the first high-end electroporator specialist in China. The flow electroporator X-Porator F1, launched in Oct. 2018, is capable of electrotransfecting up to 250ml cell solution or 1´1010 cells with satisfactory efficiency and cell viability, and achieved great success in antibody and biologics drug development applications. It has demonstrated ability to increase protein production up to 3-50 times. The flow electroporator designed for immunotherapy applications, X-Porator M1, is planned to launch in first half of 2019, will be an effective equipment in CAR-T and CAR-NK production, and help in the fight against cancer to save lives.